medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2022, Number 3

<< Back

Rev Mex Urol 2022; 82 (3)

Transformation of prostate adenocarcinoma to squamous. Case report and literature review

Macías HH, Muñoz-Lumbreras EG, Arias-Patiño JJG, García-Ortiz R, Aragón-Castro MA, Ruvalcaba-Oceguera GE, Gutiérrez-Rosales R, Santana-Maya E, Dolores-Velázquez R, Rosales-Velázquez CE

Language: Spanish
References: 15
Page:
PDF size: 555.50 Kb.


ABSTRACT

Clinical case description: A 65-year-old male who came to the emergency room due to non-clot-forming holomictional hematuria. Diagnostic approach is started, identifying in the medical history the diagnosis of prostate adenocarcinoma stage 4 without radiotherapy. Due to the patient’s symptoms, surgical treatment is performed, where squamous carcinoma of the prostate is reported. Therefore, the evolution and treatment of the patient is monitored
Relevance: It is known that patients with squamous cell carcinoma of the prostate have a short survival from the moment of diagnosis. There are few case reports on this entity and its treatment of choice.
Clinical implications: There is not a enough data to determine the management of this type of patients. The reported incidence is minimal and there is no specific treatment for these patients.
Conclusion: Squamous cell carcinoma of the prostate is a rare entity. There is little information on the possible management and prognosis in this type of cancer is adverse. Therefore, it is of the utmost importance to open new areas of research on this type of cancer.


REFERENCES

  1. Sarma DP, Weilbaecher TG, Moon TD.Squamous cell carcinoma of prostate.Urology. 1991;37(3):260–2. doi: https://doi.org/10.1016/0090-4295(91)80299-M

  2. Moskovitz B, Munichor M, Bolkier M, LivnePM. Squamous Cell Carcinoma of the Prostate.UIN. 1993;51(3):181–3. doi: https://doi.org/10.1159/000282540

  3. Lee J. Transformation of adenocarcinomaof prostate to squamous cell carcinomafollowing hormonal treatment: A case reportand review of the literature. Radiology CaseReports. 2019;14(4):483–9. doi: https://doi.org/10.1016/j.radcr.2019.01.015

  4. Braslis KG, David RC, Nelson E, Civantos F,Soloway MS. Squamous cell carcinoma of theprostate: a transformation from adenocarcinomaafter the use of a luteinizing hormonereleasinghormone agonist and flutamide.Urology. 1995;45(2):329–31. doi: https://doi.org/10.1016/0090-4295(95)80028-X

  5. Al–Qassim Z, Mohammed A, Payne D, StocksPJ, Khan Z. Squamous cell carcinoma of theprostate following treatment with an LHRH–agonist: a rare case of transformation ofadenocarcinoma of the prostate. Cent EuropeanJ Urol. 2014;67(1):26–8. doi: https://doi.org/10.5173/ceju.2014.01.art5

  6. Matsugasumi T, Nakanishi H, Yokota T,Shiraishi T, Ukimura O. Prostate squamous cellcarcinoma developing 11 years after externalradiotherapy for prostate adenocarcinoma. IJUCase Reports. 2020;3(4):121–4. doi: https://doi.org/10.1002/iju5.12161

  7. Munoz F, Franco P, Ciammella P, Clerico M,Giudici M, Filippi AR, et al. Squamous cellcarcinoma of the prostate: long-term survivalafter combined chemo-radiation. RadiationOncology. 2007;2(1):15. doi: https://doi.org/10.1186/1748-717X-2-15

  8. Biswas T, Podder T, Lepera PA, WalkerP. Primary squamous cell carcinoma of theprostate: a case report of a rare clinical entity.Future Science OA. 2015;1(3). doi: https://doi.org/10.4155/fso.15.16

  9. Wernert N, Goebbels R, Bonkhoff H, DhomG. Squamous cell carcinoma of the prostate.Histopathology. 1990;17(4):339–44. doi:https://doi.org/10.1111/j.1365-2559.1990.tb00738.x

  10. Okada E, Kamizaki H. Primary squamouscell carcinoma of the prostate. Int J Urol.2000;7(9):347–50. doi: https://doi.org/10.1046/j.1442-2042.2000.00204.x.

  11. He X, Yang K, Chen G, Zheng J. Squamous cellcarcinoma of the prostate with lower urinarytract symptoms: A case report. Urol Case Rep.2021;39:101796. doi: https://doi.org/10.1016/j.eucr.2021.101796

  12. Hutten RJ, Weil CR, Tward JD, Lloyd S, JohnsonSB. Patterns of Care and Treatment Outcomes inLocoregional Squamous Cell Carcinoma of theProstate. Eur Urol Open Sci. 2021;23:30–3. doi:https://doi.org/10.1016/j.euros.2020.11.008.

  13. Little NA, Wiener JS, Walther PJ, Paulson DF,Anderson EE. Squamous cell carcinoma of theprostate: 2 cases of a rare malignancy and reviewof the literature. J Urol. 1993;149(1):137–9. doi: https://doi.org/10.1016/s0022-5347(17)36024-x

  14. Atagi K, Fukuhara H, Ishiguro M, Osakabe H,Satoshi F, Tamura K, et al. Successful treatmentwith DCF chemotherapy and radiotherapyfor primary squamous cell carcinoma of theprostate. IJU Case Rep. 2021;4(6):421–4. doi:https://doi.org/10.1002/iju5.12365

  15. Onoda M, Sugimoto R, Uesugi N, TakayamaM, Shiomi E, Kato R, et al. Novel combinationchemotherapy with radiotherapy for prostatesquamous cell carcinoma. Int Cancer Conf J.2017;6(1):25–8. doi: https://doi.org/10.1007/s13691-016-0266-6




2020     |     www.medigraphic.com